Novel Peptide Hit Identification and Lead Generating Strategies for Drug Discovery
Related Content
The EML4-ALK fusion gene occurs in approximately 5% of non-small-cell lung cancers (NSCLCs), making this oncogene an important drug target. ...
VIEW RESOURCELearn about our semi-automated chromatography platform for parallel purification of high-quality therapeutic targets. At PEGS Europe 2023, WuXi AppTec scientists...
VIEW RESOURCE